论文部分内容阅读
β受体阻滞剂可降低心肌梗死后的死亡率,并改善收缩性心力衰竭患者的预后;可减少高风险患者手术前治疗的不良事件;在较年轻的患者中(60岁以下),β受体阻滞剂的疗效与其它抗高血压药物相似;β受体阻滞剂可能改善冠心病的预后,并延缓疾病的进展;在预防高血压患者的心血管事件方面,阿替洛尔的疗效可能不如其它β受体阻滞剂以及其它抗高血压药物。
β-blockers reduce post-MI mortality and improve prognosis in patients with systolic heart failure; reduce the risk of preoperative adverse events in high-risk patients; in younger patients (under 60 years of age), β Receptor blockers and other antihypertensive drugs similar efficacy; β-blockers may improve the prognosis of coronary heart disease, and delay the progress of the disease; in the prevention of cardiovascular events in patients with atenolol Efficacy may not be as good as other beta-blockers and other anti-hypertensive drugs.